Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma

Journal of Clinical Pathology

Volumn 65, Issue 3, 2012, Pages 248-253

  Tai, Hui Chun ^a,b   Huang, Hsuan Ying ^c   Lee, Sung Wei ^d   Lin, Ching Yih ^d   Sheu, Ming Jen ^d   Chang, Shih Lun ^d   Wu, Li Ching ^d   Shiue, Yow Ling ^e   Wu, Wen Ren ^e   Lin, Chun Mao ^f   Li, Chien Feng ^d,e,g,h  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^h SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NUCLEAR PROTEIN; PROTEIN RSF 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR BIOPSY;

CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUCLEAR PROTEINS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TRANS-ACTIVATORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84857372786     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200413     Document Type: Article

References (26)

1. Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol 2008;20:264-9.
2. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-9.
3. Cancer Registry Annual Report, the Bureau of Health Promotion, Taiwan. http://www.bhp.doh.gov.tw/BHPNET/Portal/Statistics.aspx
4. Chan JKC, Bray F, McCarron P, et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, et al, eds. World Health Organization Classification of Tumors - Pathology & Genetics: Head and Neck Tumors. Lyon, IARC Press, 2005:85-97.
5. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:451-62.
6. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005;61:1107-16.
7. Choi JH, Sheu JJ, Guan B, et al. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res 2009;69:1407-15.
8. Fang FM, Li CF, Huang HY, et al. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. Am J Pathol 2011;178:2407-15.
9. Hui AB, Or YY, Takano H, et al. Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005;65:8125-33.
10. Shih Ie M, Sheu JJ, Santillan A, et al. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci U S A 2005;102:14004-9.
11. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998;20:473-9.
12. Sheu JJ, Guan B, Choi JH, et al. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J Biol Chem 2010;285:38260-9.
13. Loyola A, Huang JY, LeRoy G, et al. Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol 2003;23:6759-68.
14. Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010.
15. Wolden SL, Zelefsky MJ, Kraus DH, et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1105-10.
16. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7.
17. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000;60:3348-53.
18. Wang GG, Allis CD, Chi P, et al. Chromatin remodeling and cancer. Part II: ATPdependent chromatin remodeling. Trends Mol Med 2007;13:373-80.
19. Wolffe AP. Chromatin remodeling: why it is important in cancer. Oncogene 2001;20:2988-90.
20. Cosma MP, Tanaka T, Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 1999;97:299-311.
21. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene 2009;28:1653-68.
22. Roberts CW, Orkin SH. The SWI/SNF complex - chromatin and cancer. Nat Rev Cancer 2004;4:133-42.
23. Shamay M, Barak O, Shaul Y. HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics 2002;79:523-9.
24. Sheu JJ, Choi JH, Yildiz I, et al. The roles of human sucrose nonfermenting protein 2 homologue in the tumour-promoting functions of Rsf-1. Cancer Res 2008;68:4050-7.
25. Maeda D, Chen X, Guan B, et al. Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma. Int J Gynecol Pathol 2011;30:30-5.
26. Mao TL, Hsu CY, Yen MJ, et al. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum Pathol 2006;37:1169-75.